Integrated analysis of multiple biomarkers from circulating tumor cells enabled by exclusion-based analyte isolation

PURPOSE: There is a critical clinical need for new predictive and pharmacodynamic biomarkers that evaluate pathway activity in patients treated with targeted therapies. A microscale platform known as VERSA (Versatile Exclusion-based Rare Sample Analysis) was developed to integrate readouts across pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Sperger, Jamie M., Strotman, Lindsay N., Welsh, Allison, Casavant, Benjamin P., Chalmers, Zachery, Horn, Sacha, Heninger, Erika, Thiede, Stephanie M., Tokar, Jacob, Gibbs, Benjamin K., Guckenberger, David J., Carmichael, Lakeesha, Dehm, Scott M., Stephens, Philip J., Beebe, David J., Berry, Scott M., Lang, Joshua M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226928/
https://ncbi.nlm.nih.gov/pubmed/27401243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados